Where can I read EW's latest 10-K?

EW's latest annual report, a 10-K, was filed on Feb 25, 2026 for the fiscal year ended Dec 31, 2025. It is linked above and opens on EDGAR, the SEC's own site, where every exhibit is also listed.

When did EW last file an 8-K?

On Aug 28, 2026 it covered directors or officers; compensation. An 8-K reports a material event between quarterly reports; the one that furnishes the quarter's results is filed under Item 2.02, last on Jul 23, 2026.

Are EW insiders buying or selling?

Over the last 13 months insiders sold $21.3M in 32 sales and bought nothing on the open market; 122 other transactions (awards, exercises, tax withholding, gifts and plan purchases). The most recent sale: Lippis Daniel J. (CVP, TAVR) sold 619 shares on Oct 8, 2026 for $53K, under a 10b5-1 plan. Every figure is as the insider filed it on Form 4; a sale under a 10b5-1 plan was scheduled in advance.

How many SEC filings has EW made?

2,602 filings are on EDGAR under the registrant records that have been Edwards Lifesciences Corporation, going back to 1999; 1,965 of them are insider ownership forms (Forms 3, 4, 5 and 144).

$88.39+0.11%

as of close, Oct 21, 2026

☾ AH $88.39 +0.11%

Edwards Lifesciences CorporationStock · HealthcareS&P 500 Equal Weight · 0.2% of RSPS&P 500 · 0.08% of SPYRussell 1000 · 0.07% of IWBUS Stock Market · 0.07% of VTIRussell 3000 · 0.07% of IWVMSCI World · 0.06% of URTHMSCI ACWI · 0.05% of ACWI

PeersBSXSYKDXCMMDTGEHCSTE

Share this page

EW SEC filings (2026)

CIK 1099800 · Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842) · incorporated in DE · fiscal year ends in December

2,602 filings on EDGAR since 1999 · 27 annual, 82 quarterly, 205 current · financial statements · earnings

Latest 10-K

Feb 25, 2026

fiscal year to Dec 31, 2025

Latest 10-Q

Aug 4, 2026

quarter to Jun 30, 2026

Latest 8-K

Aug 28, 2026

Directors or officers; compensation

Last earnings release

Jul 23, 2026

$0.78 vs $0.73 · ▼ 1.4%

Filings on file

2,602

since 1999, 1,965 insider forms

What happened, last 12 months#

Every earnings release with its print, every report with its quarter, the other 8-Ks by the headline of the press release they furnish or by their items, the proxy statements, and each day an insider bought or sold — newest first, each line opening the filing on EDGAR. The index by form and year follows.

Insider transactions#

What officers, directors and 10% holders reported on Forms 4 and 5 over the last 13 months, from the documents themselves: one insider’s trades of one kind on one day are one row, with the shares, the price range and the total as filed. Open-market buys and sells first; awards, exercises, tax withholding, gifts and employee-plan purchases are grouped below them.

Over the last 13 months insiders sold $21.3M in 32 sales and bought nothing on the open market; 122 other transactions (awards, exercises, tax withholding, gifts and plan purchases).

Date	Insider	Action	Shares	Price	Value	Held after	Filing
Oct 8, 2026Form 4	Lippis Daniel J.CVP, TAVRSold · $53K · 619 sh · 10b5-1	Sold· 10b5-1 plan	619	$85.65	$53K	40,033.91	Form 4
Sep 11, 2026Form 4	Lippis Daniel J.CVP, TAVRSold · $54K · 619 sh · 10b5-1	Sold· 10b5-1 plan	619	$87.51	$54K	40,033.91	Form 4
Aug 31, 2026Form 4	Dahl Andrew M.SVP, Corporate ControllerSold · $50K · 544 sh	Sold	544	$91.06	$50K	14,868.41	Form 4
Aug 28, 2026Form 4	Bruls AnnetteCVP, EMEACLASold · $238K · 2,644 sh	Sold	2,644	$89.98	$238K	17,984	Form 4
Aug 26, 2026Form 4	Chopra DaveenCVP, TMTT, Surgical & IHFMSold · $2.9M · 31,800 sh	Sold	31,800	$90.99–$91.76	$2.9M	44,324	Form 4
Aug 26, 2026Form 4	Markowitz WayneCVP, JAPACSold · $113K · 1,240 sh	Sold	1,240	$91.47	$113K	20,293.558	Form 4
Aug 11, 2026Form 4	Lippis Daniel J.CVP, TAVRSold · $57K · 619 sh · 10b5-1	Sold· 10b5-1 plan	619	$92.03	$57K	40,033.91	Form 4
Jul 30, 2026Form 4	Markowitz WayneCVP, JAPACSold · $13K · 146.313 sh	Sold	146.313	$86.03	$13K	21,533.558	Form 4
Jul 28, 2026Form 4	Markowitz WayneCVP, JAPACSold · $819K · 9,628 sh	Sold	9,628	$85.06	$819K	21,679.871	Form 4
Jul 27, 2026Form 4	Zovighian Bernard JCEO · DirectorSold · $245K · 2,920.551 sh	Sold	2,920.551	$83.93	$245K	8,915.65	Form 4
Jul 10, 2026Form 4	Lippis Daniel J.CVP, TAVRSold · $57K · 619 sh · 10b5-1	Sold· 10b5-1 plan	619	$91.70	$57K	40,033.91	Form 4
Jun 30, 2026Form 4	Lippis Daniel J.CVP, TAVRSold · $57K · 619 sh · 10b5-1	Sold· 10b5-1 plan	619	$91.40	$57K	40,410.91	Form 4
Jun 17, 2026Form 4	Zovighian Bernard JCEO · DirectorSold · $46K · 523 sh · 10b5-1	Sold· 10b5-1 plan	523	$87.92	$46K	11,516.551	Form 4
May 29, 2026Form 4	Dahl Andrew M.SVP, Corporate ControllerSold · $49K · 567.527 sh	Sold	567.527	$86.08	$49K	15,334.095	Form 4
May 27, 2026Form 4	BOBO DONALD E JRCVP,Strategy/Corp DevelopmentSold · $2.0M · 23,145 sh	Sold	23,145	$86.42	$2.0M	98,611	Form 4
May 22, 2026Form 4	Chopra DaveenCVP, TMTT & SurgicalSold · $127K · 1,500 sh	Sold	1,500	$84.60	$127K	44,324	Form 4
May 18, 2026Form 4	Lippis Daniel J.CVP, TAVRSold · $50K · 620 sh · 10b5-1	Sold· 10b5-1 plan	620	$81.14	$50K	40,410.91	Form 4
May 15, 2026Form 4	BOBO DONALD E JRCVP,Strategy/Corp DevelopmentSold · $1.5M · 17,968 sh	Sold	17,968	$81.82–$82.07	$1.5M	53,767.829	Form 4
May 12, 2026Form 4	Zovighian Bernard JCEO · DirectorSold · $2.8M · 36,351 sh · 10b5-1	Sold· 10b5-1 plan	36,351	$77.92–$78.40	$2.8M	12,039.551	Form 4
May 11, 2026Form 4	Markowitz WayneCVP, JAPACSold · $47K · 593 sh	Sold	593	$79.73	$47K	21,679.871	Form 4
May 4, 2026Form 4	Lippis Daniel J.CVP, TAVRSold · $86K · 1,019 sh · 10b5-1	Sold· 10b5-1 plan	1,019	$83.98	$86K	33,681.91	Form 4
May 1, 2026Form 4	Lippis Daniel J.CVP, TAVRSold · $85K · 1,019 sh · 10b5-1	Sold· 10b5-1 plan	1,019	$82.99–$83.99	$85K	33,933.91	Form 4
Apr 9, 2026Form 4	Ullem Scott B.CVP, Chief Financial OfficerSold · $1.0M · 13,000 sh · 10b5-1	Sold· 10b5-1 plan	13,000	$79.79–$80.50	$1.0M	39,699	Form 4
Apr 6, 2026Form 4	Lippis Daniel J.CVP, TAVRSold · $83K · 1,019 sh · 10b5-1	Sold· 10b5-1 plan	1,019	$80.98	$83K	33,933.91	Form 4
Apr 2, 2026Form 4	BOBO DONALD E JRCVP,Strategy/Corp DevelopmentSold · $1.8M · 22,680 sh · 10b5-1	Sold· 10b5-1 plan	22,680	$80.05–$80.59	$1.8M	21,266.253	Form 4
Mar 11, 2026Form 4	Ullem Scott B.CVP, Chief Financial OfficerSold · $1.1M · 13,000 sh · 10b5-1	Sold· 10b5-1 plan	13,000	$84.46–$85.21	$1.1M	39,699	Form 4
Mar 11, 2026Form 4	Lippis Daniel J.CVP, TAVRSold · $87K · 1,019 sh · 10b5-1	Sold· 10b5-1 plan	1,019	$85.38	$87K	33,933.91	Form 4
Mar 2, 2026Form 4	BOBO DONALD E JRCVP,Strategy/Corp DevelopmentSold · $974K · 11,340 sh · 10b5-1	Sold· 10b5-1 plan	11,340	$85.93	$974K	21,266.253	Form 4
Feb 25, 2026Form 4	BOBO DONALD E JRCVP,Strategy/Corp DevelopmentSold · $2.0M · 24,000 sh	Sold	24,000	$83.84	$2.0M	21,266.253	Form 4
Feb 12, 2026Form 4	Zovighian Bernard JCEO · DirectorSold · $1.7M · 22,430 sh	Sold	22,430	$76.61–$77.13	$1.7M	83,896	Form 4
Jan 9, 2026Form 4	Lippis Daniel J.CVP, TAVRSold · $87K · 1,019 sh · 10b5-1	Sold· 10b5-1 plan	1,019	$85.70	$87K	22,001.91	Form 4
Jan 6, 2026Form 4	BOBO DONALD E JRCVP,Strategy/Corp DevelopmentSold · $971K · 11,340 sh · 10b5-1	Sold· 10b5-1 plan	11,340	$84.62–$85.98	$971K	31,870.253	Form 4

Awards, exercises, withholding and plan purchases · 122 transactions

Date	Insider	Action	Shares	Price	Value	Held after	Filing
Oct 8, 2026Form 4	Lippis Daniel J.CVP, TAVRExercise or conversion · $45K · 619 sh · 10b5-1	Exercise or conversion· 10b5-1 plan	619	$72.68	$45K	40,652.91	Form 4
Oct 8, 2026Form 4	Lippis Daniel J.CVP, TAVRExercise or conversion · Employee Stock Option (Rig… · $0 · 619 sh · 10b5-1	Exercise or conversion· Employee Stock Option (Rig…· 10b5-1 plan	619	$0.00	$0	3,095	Form 4
Sep 14, 2026Form 4	Markowitz WayneCVP, JAPACTax withholding · $48K · 568 sh	Tax withholding	568	$84.37	$48K	19,370.558	Form 4
Sep 13, 2026Form 4	Dahl Andrew M.SVP, Corporate ControllerTax withholding · $21K · 253 sh	Tax withholding	253	$84.37	$21K	14,615.41	Form 4
Sep 11, 2026Form 4	Lippis Daniel J.CVP, TAVRExercise or conversion · $45K · 619 sh · 10b5-1	Exercise or conversion· 10b5-1 plan	619	$72.68	$45K	40,652.91	Form 4
Sep 11, 2026Form 4	Chopra DaveenCVP, TMTT, Surgical & IHFMTax withholding · $35K · 398 sh	Tax withholding	398	$86.77	$35K	43,926	Form 4
Sep 11, 2026Form 4	Markowitz WayneCVP, JAPACTax withholding · $31K · 355 sh	Tax withholding	355	$86.77	$31K	19,938.558	Form 4
Sep 11, 2026Form 4	Lippis Daniel J.CVP, TAVRExercise or conversion · Employee Stock Option (Rig… · $0 · 619 sh · 10b5-1	Exercise or conversion· Employee Stock Option (Rig…· 10b5-1 plan	619	$0.00	$0	3,714	Form 4
Aug 26, 2026Form 4	Chopra DaveenCVP, TMTT, Surgical & IHFMExercise or conversion · $2.3M · 31,800 sh	Exercise or conversion	31,800	$72.68	$2.3M	76,124	Form 4
Aug 26, 2026Form 4	Chopra DaveenCVP, TMTT, Surgical & IHFMExercise or conversion · Employee Stock Option (Rig… · $0 · 31,800 sh	Exercise or conversion· Employee Stock Option (Rig…	31,800	$0.00	$0	0	Form 4
Aug 11, 2026Form 4	Lippis Daniel J.CVP, TAVRExercise or conversion · $45K · 619 sh · 10b5-1	Exercise or conversion· 10b5-1 plan	619	$72.68	$45K	40,652.91	Form 4
Aug 11, 2026Form 4	Lippis Daniel J.CVP, TAVRExercise or conversion · Employee Stock Option (Rig… · $0 · 619 sh · 10b5-1	Exercise or conversion· Employee Stock Option (Rig…· 10b5-1 plan	619	$0.00	$0	4,333	Form 4
Jul 28, 2026Form 4	Markowitz WayneCVP, JAPACExercise or conversion · $713K · 9,628 sh	Exercise or conversion	9,628	$74.02	$713K	31,307.871	Form 4
Jul 28, 2026Form 4	Markowitz WayneCVP, JAPACExercise or conversion · Employee Stock Option (Rig… · $0 · 9,628 sh	Exercise or conversion· Employee Stock Option (Rig…	9,628	$0.00	$0	9,628	Form 4
Jul 27, 2026Form 4	Zovighian Bernard JCEO · DirectorGift · $0 · 639.3 sh	Gift	639.3	$0.00	$0	110,681.201	Form 4
Jul 11, 2026Form 4	Bruls AnnetteCVP, EMEACLATax withholding · $10K · 109 sh	Tax withholding	109	$92.21	$10K	20,628	Form 4
Jul 10, 2026Form 4	Lippis Daniel J.CVP, TAVRExercise or conversion · $45K · 619 sh · 10b5-1	Exercise or conversion· 10b5-1 plan	619	$72.68	$45K	40,652.91	Form 4
Jul 10, 2026Form 4	Lippis Daniel J.CVP, TAVRExercise or conversion · Employee Stock Option (Rig… · $0 · 619 sh · 10b5-1	Exercise or conversion· Employee Stock Option (Rig…· 10b5-1 plan	619	$0.00	$0	4,952	Form 4
Jul 9, 2026Form 4	Mistras TheodoraCVP, Chief Financial OfficerAward · $0 · 99,920 sh	Award	99,920	$0.00	$0	99,920	Form 4
Jul 9, 2026Form 4	Mistras TheodoraCVP, Chief Financial OfficerAward · Employee Stock Option (Rig… · $0 · 61,800 sh	Award· Employee Stock Option (Rig…	61,800	$0.00	$0	61,800	Form 4
Jul 9, 2026Form 4	Mistras TheodoraCVP, Chief Financial OfficerAward · $0 · 12,325 sh	Award	12,325	$0.00	$0	12,325	Form 4
Jul 7, 2026Form 4	Lippis Daniel J.CVP, TAVRTax withholding · $36K · 377 sh	Tax withholding	377	$95.18	$36K	40,033.91	Form 4
Jun 30, 2026Form 4	Lippis Daniel J.CVP, TAVRExercise or conversion · $45K · 619 sh · 10b5-1	Exercise or conversion· 10b5-1 plan	619	$72.68	$45K	41,029.91	Form 4
Jun 30, 2026Form 4	Lippis Daniel J.CVP, TAVRExercise or conversion · Employee Stock Option (Rig… · $0 · 619 sh · 10b5-1	Exercise or conversion· Employee Stock Option (Rig…· 10b5-1 plan	619	$0.00	$0	5,571	Form 4
May 18, 2026Form 4	Lippis Daniel J.CVP, TAVRExercise or conversion · $45K · 620 sh · 10b5-1	Exercise or conversion· 10b5-1 plan	620	$72.68	$45K	41,030.91	Form 4
May 18, 2026Form 4	Lippis Daniel J.CVP, TAVRExercise or conversion · Employee Stock Option (Rig… · $0 · 620 sh · 10b5-1	Exercise or conversion· Employee Stock Option (Rig…· 10b5-1 plan	620	$0.00	$0	6,190	Form 4
May 12, 2026Form 4	Zovighian Bernard JCEO · DirectorGift · $0 · 53,280 sh · 10b5-1	Gift· 10b5-1 plan	53,280	$0.00	$0	147,555.201	Form 4
May 11, 2026Form 4	Zovighian Bernard JCEO · DirectorTax withholding · $2.1M · 26,198 sh · 10b5-1	Tax withholding· 10b5-1 plan	26,198	$79.96	$2.1M	125,804.65	Form 4
May 11, 2026Form 4	Ullem Scott B.CVP, Chief Financial OfficerTax withholding · $880K · 11,004 sh	Tax withholding	11,004	$79.96	$880K	46,740	Form 4
May 11, 2026Form 4	Chopra DaveenCVP, TMTT & SurgicalTax withholding · $603K · 7,538 sh	Tax withholding	7,538	$79.96	$603K	45,824	Form 4
May 11, 2026Form 4	BOBO DONALD E JRCVP,Strategy/Corp DevelopmentTax withholding · $597K · 7,469 sh	Tax withholding	7,469	$79.96	$597K	32,766.253	Form 4
May 11, 2026Form 4	Lippis Daniel J.CVP, TAVRTax withholding · $29K · 362 sh	Tax withholding	362	$79.96	$29K	40,410.91	Form 4
May 11, 2026Form 4	Zovighian Bernard JCEO · DirectorExercise or conversion · $0 · 47,207 sh · 10b5-1	Exercise or conversion· 10b5-1 plan	47,207	$0.00	$0	157,491.65	Form 4
May 11, 2026Form 4	Zovighian Bernard JCEO · DirectorExercise or conversion · $0 · 47,207 sh · 10b5-1	Exercise or conversion· 10b5-1 plan	47,207	$0.00	$0	0	Form 4
May 11, 2026Form 4	Ullem Scott B.CVP, Chief Financial OfficerExercise or conversion · $0 · 19,830 sh	Exercise or conversion	19,830	$0.00	$0	57,744	Form 4
May 11, 2026Form 4	Ullem Scott B.CVP, Chief Financial OfficerExercise or conversion · $0 · 19,830 sh	Exercise or conversion	19,830	$0.00	$0	0	Form 4
May 11, 2026Form 4	Chopra DaveenCVP, TMTT & SurgicalExercise or conversion · $0 · 13,583 sh	Exercise or conversion	13,583	$0.00	$0	53,362	Form 4
May 11, 2026Form 4	Chopra DaveenCVP, TMTT & SurgicalExercise or conversion · $0 · 13,583 sh	Exercise or conversion	13,583	$0.00	$0	0	Form 4
May 11, 2026Form 4	BOBO DONALD E JRCVP,Strategy/Corp DevelopmentExercise or conversion · $0 · 13,457 sh	Exercise or conversion	13,457	$0.00	$0	40,235.253	Form 4
May 11, 2026Form 4	BOBO DONALD E JRCVP,Strategy/Corp DevelopmentExercise or conversion · $0 · 13,457 sh	Exercise or conversion	13,457	$0.00	$0	0	Form 4
May 11, 2026Form 4	Zovighian Bernard JCEO · DirectorGift · $0 · 10,978 sh	Gift	10,978	$0.00	$0	126,546.201	Form 4
May 8, 2026Form 4	Zovighian Bernard JCEO · DirectorTax withholding · $447K · 5,398 sh	Tax withholding	5,398	$82.76	$447K	110,284.65	Form 4
May 8, 2026Form 4	Ullem Scott B.CVP, Chief Financial OfficerTax withholding · $137K · 1,661 sh	Tax withholding	1,661	$82.76	$137K	37,914	Form 4
May 8, 2026Form 4	Chopra DaveenCVP, TMTT & SurgicalTax withholding · $94K · 1,141 sh	Tax withholding	1,141	$82.76	$94K	39,779	Form 4
May 8, 2026Form 4	BOBO DONALD E JRCVP,Strategy/Corp DevelopmentTax withholding · $86K · 1,038 sh	Tax withholding	1,038	$82.76	$86K	26,778.253	Form 4
May 8, 2026Form 4	Lippis Daniel J.CVP, TAVRTax withholding · $37K · 450 sh	Tax withholding	450	$82.76	$37K	40,772.91	Form 4
May 8, 2026Form 4	Dahl Andrew M.SVP, Corporate ControllerTax withholding · $24K · 289 sh	Tax withholding	289	$82.76	$24K	15,901.621	Form 4
May 8, 2026Form 4	Markowitz WayneCVP, JAPACTax withholding · $19K · 226 sh	Tax withholding	226	$82.76	$19K	22,272.871	Form 4
May 8, 2026Form 4	Bruls AnnetteCVP, EMEACLATax withholding · $6,952 · 84 sh	Tax withholding	84	$82.76	$6,952	20,737	Form 4
May 8, 2026Form 4	Zovighian Bernard JCEO · DirectorGift · $0 · 8,444 sh	Gift	8,444	$0.00	$0	131,944.201	Form 4
May 8, 2026Form 4	VALERIANI NICHOLAS JDirectorAward · $0 · 5,127 sh	Award	5,127	$0.00	$0	84,423	Form 4
May 8, 2026Form 4	GALLAHUE KIERANDirectorAward · $0 · 4,315 sh	Award	4,315	$0.00	$0	4,315	Form 4
May 8, 2026Form 4	LORANGER STEVEN RDirectorAward · $0 · 4,315 sh	Award	4,315	$0.00	$0	8,997	Form 4
May 8, 2026Form 4	Davis Leslie C.DirectorAward · $0 · 3,251 sh	Award	3,251	$0.00	$0	9,834	Form 4
May 8, 2026Form 4	Feinberg David TDirectorAward · $0 · 3,251 sh	Award	3,251	$0.00	$0	9,087	Form 4
May 8, 2026Form 4	STONE HEISZ LESLIEDirectorAward · $0 · 3,251 sh	Award	3,251	$0.00	$0	34,199	Form 4
May 8, 2026Form 4	LAVIOLETTE PAUL ADirectorAward · $0 · 3,251 sh	Award	3,251	$0.00	$0	17,552	Form 4
May 8, 2026Form 4	Sequeira RamonaDirectorAward · $0 · 3,251 sh	Award	3,251	$0.00	$0	6,779	Form 4
May 7, 2026Form 4	Zovighian Bernard JCEO · DirectorTax withholding · $346K · 4,153 sh	Tax withholding	4,153	$83.20	$346K	119,904.65	Form 4
May 7, 2026Form 4	Ullem Scott B.CVP, Chief Financial OfficerTax withholding · $114K · 1,373 sh	Tax withholding	1,373	$83.20	$114K	39,575	Form 4
May 7, 2026Form 4	BOBO DONALD E JRCVP,Strategy/Corp DevelopmentTax withholding · $69K · 831 sh	Tax withholding	831	$83.20	$69K	27,816.253	Form 4
May 7, 2026Form 4	Chopra DaveenCVP, TMTT & SurgicalTax withholding · $56K · 674 sh	Tax withholding	674	$83.20	$56K	40,920	Form 4
May 7, 2026Form 4	Lippis Daniel J.CVP, TAVRTax withholding · $26K · 309 sh	Tax withholding	309	$83.20	$26K	41,222.91	Form 4
May 7, 2026Form 4	Markowitz WayneCVP, JAPACTax withholding · $22K · 264 sh	Tax withholding	264	$83.20	$22K	22,498.871	Form 4
May 7, 2026Form 4	Zovighian Bernard JCEO · DirectorAward · Employee Stock Option (Rig… · $0 · 245,300 sh	Award· Employee Stock Option (Rig…	245,300	$0.00	$0	245,300	Form 4
May 7, 2026Form 4	Chopra DaveenCVP, TMTT & SurgicalAward · Employee Stock Option (Rig… · $0 · 49,100 sh	Award· Employee Stock Option (Rig…	49,100	$0.00	$0	49,100	Form 4
May 7, 2026Form 4	BOBO DONALD E JRCVP,Strategy/Corp DevelopmentAward · Employee Stock Option (Rig… · $0 · 44,000 sh	Award· Employee Stock Option (Rig…	44,000	$0.00	$0	44,000	Form 4
May 7, 2026Form 4	Zovighian Bernard JCEO · DirectorAward · $0 · 43,800 sh	Award	43,800	$0.00	$0	124,057.65	Form 4
May 7, 2026Form 4	Zovighian Bernard JCEO · DirectorAward · $0 · 43,800 sh	Award	43,800	$0.00	$0	43,800	Form 4
May 7, 2026Form 4	Lippis Daniel J.CVP, TAVRAward · Employee Stock Option (Rig… · $0 · 39,900 sh	Award· Employee Stock Option (Rig…	39,900	$0.00	$0	39,900	Form 4
May 7, 2026Form 4	Bruls AnnetteCVP, EMEACLAAward · Employee Stock Option (Rig… · $0 · 33,700 sh	Award· Employee Stock Option (Rig…	33,700	$0.00	$0	33,700	Form 4
May 7, 2026Form 4	Markowitz WayneCVP, JAPACAward · Employee Stock Option (Rig… · $0 · 26,400 sh	Award· Employee Stock Option (Rig…	26,400	$0.00	$0	26,400	Form 4
May 7, 2026Form 4	Chopra DaveenCVP, TMTT & SurgicalAward · $0 · 9,675 sh	Award	9,675	$0.00	$0	41,594	Form 4
May 7, 2026Form 4	Chopra DaveenCVP, TMTT & SurgicalAward · $0 · 9,675 sh	Award	9,675	$0.00	$0	9,675	Form 4
May 7, 2026Form 4	Lippis Daniel J.CVP, TAVRAward · $0 · 7,850 sh	Award	7,850	$0.00	$0	41,531.91	Form 4
May 7, 2026Form 4	Lippis Daniel J.CVP, TAVRAward · $0 · 7,850 sh	Award	7,850	$0.00	$0	7,850	Form 4
May 7, 2026Form 4	BOBO DONALD E JRCVP,Strategy/Corp DevelopmentAward · $0 · 7,850 sh	Award	7,850	$0.00	$0	28,647.253	Form 4
May 7, 2026Form 4	BOBO DONALD E JRCVP,Strategy/Corp DevelopmentAward · $0 · 7,850 sh	Award	7,850	$0.00	$0	7,850	Form 4
May 7, 2026Form 4	Dahl Andrew M.SVP, Corporate ControllerAward · $0 · 7,005 sh	Award	7,005	$0.00	$0	16,190.621	Form 4
May 7, 2026Form 4	Dahl Andrew M.SVP, Corporate ControllerAward · Employee Stock Option (Rig… · $0 · 6,745 sh	Award· Employee Stock Option (Rig…	6,745	$0.00	$0	6,745	Form 4
May 7, 2026Form 4	Bruls AnnetteCVP, EMEACLAAward · $0 · 6,650 sh	Award	6,650	$0.00	$0	20,821	Form 4
May 7, 2026Form 4	Bruls AnnetteCVP, EMEACLAAward · $0 · 6,650 sh	Award	6,650	$0.00	$0	6,650	Form 4
May 7, 2026Form 4	Markowitz WayneCVP, JAPACAward · $0 · 5,200 sh	Award	5,200	$0.00	$0	22,762.871	Form 4
May 7, 2026Form 4	Markowitz WayneCVP, JAPACAward · $0 · 5,200 sh	Award	5,200	$0.00	$0	5,200	Form 4
May 5, 2026Form 4	Ullem Scott B.CVP, Chief Financial OfficerTax withholding · $923K · 11,131 sh	Tax withholding	11,131	$82.91	$923K	40,948	Form 4
May 5, 2026Form 4	Ullem Scott B.CVP, Chief Financial OfficerExercise or conversion · $770K · 13,000 sh	Exercise or conversion	13,000	$59.26	$770K	52,079	Form 4
May 5, 2026Form 4	Ullem Scott B.CVP, Chief Financial OfficerExercise or conversion · Employee Stock Option (Rig… · $0 · 13,000 sh	Exercise or conversion· Employee Stock Option (Rig…	13,000	$0.00	$0	0	Form 4
May 5, 2026Form 4	Zovighian Bernard JCEO · DirectorGift · $0 · 1,046 sh	Gift	1,046	$0.00	$0	92,297.201	Form 4
May 4, 2026Form 4	Lippis Daniel J.CVP, TAVRExercise or conversion · $60K · 1,019 sh · 10b5-1	Exercise or conversion· 10b5-1 plan	1,019	$59.26	$60K	34,700.91	Form 4
May 4, 2026Form 4	Lippis Daniel J.CVP, TAVRExercise or conversion · Employee Stock Option (Rig… · $0 · 1,019 sh · 10b5-1	Exercise or conversion· Employee Stock Option (Rig…· 10b5-1 plan	1,019	$0.00	$0	0	Form 4
May 3, 2026Form 4	Ullem Scott B.CVP, Chief Financial OfficerTax withholding · $52K · 620 sh	Tax withholding	620	$83.98	$52K	39,079	Form 4
May 3, 2026Form 4	Zovighian Bernard JCEO · DirectorTax withholding · $43K · 515 sh	Tax withholding	515	$83.98	$43K	80,780.65	Form 4
May 3, 2026Form 4	BOBO DONALD E JRCVP,Strategy/Corp DevelopmentTax withholding · $39K · 469 sh	Tax withholding	469	$83.98	$39K	20,797.253	Form 4
May 3, 2026Form 4	Chopra DaveenCVP, TMTT & SurgicalTax withholding · $24K · 282 sh	Tax withholding	282	$83.98	$24K	31,919	Form 4
May 3, 2026Form 4	Lippis Daniel J.CVP, TAVRTax withholding · $21K · 252 sh · 10b5-1	Tax withholding· 10b5-1 plan	252	$83.98	$21K	33,681.91	Form 4
May 1, 2026Form 4	Lippis Daniel J.CVP, TAVRExercise or conversion · $60K · 1,019 sh · 10b5-1	Exercise or conversion· 10b5-1 plan	1,019	$59.26	$60K	34,952.91	Form 4
May 1, 2026Form 4	Lippis Daniel J.CVP, TAVRExercise or conversion · Employee Stock Option (Rig… · $0 · 1,019 sh · 10b5-1	Exercise or conversion· Employee Stock Option (Rig…· 10b5-1 plan	1,019	$0.00	$0	1,019	Form 4
Apr 9, 2026Form 4	Ullem Scott B.CVP, Chief Financial OfficerExercise or conversion · $770K · 13,000 sh · 10b5-1	Exercise or conversion· 10b5-1 plan	13,000	$59.26	$770K	52,699	Form 4
Apr 9, 2026Form 4	Ullem Scott B.CVP, Chief Financial OfficerExercise or conversion · Employee Stock Option (Rig… · $0 · 13,000 sh · 10b5-1	Exercise or conversion· Employee Stock Option (Rig…· 10b5-1 plan	13,000	$0.00	$0	13,000	Form 4
Apr 6, 2026Form 4	Lippis Daniel J.CVP, TAVRExercise or conversion · $60K · 1,019 sh · 10b5-1	Exercise or conversion· 10b5-1 plan	1,019	$59.26	$60K	34,952.91	Form 4
Apr 6, 2026Form 4	Lippis Daniel J.CVP, TAVRExercise or conversion · Employee Stock Option (Rig… · $0 · 1,019 sh · 10b5-1	Exercise or conversion· Employee Stock Option (Rig…· 10b5-1 plan	1,019	$0.00	$0	2,038	Form 4
Apr 2, 2026Form 4	BOBO DONALD E JRCVP,Strategy/Corp DevelopmentExercise or conversion · $1.3M · 22,680 sh · 10b5-1	Exercise or conversion· 10b5-1 plan	22,680	$59.26	$1.3M	43,946.253	Form 4
Apr 2, 2026Form 4	BOBO DONALD E JRCVP,Strategy/Corp DevelopmentExercise or conversion · Employee Stock Option (Rig… · $0 · 22,680 sh · 10b5-1	Exercise or conversion· Employee Stock Option (Rig…· 10b5-1 plan	22,680	$0.00	$0	0	Form 4
Mar 11, 2026Form 4	Ullem Scott B.CVP, Chief Financial OfficerExercise or conversion · $770K · 13,000 sh · 10b5-1	Exercise or conversion· 10b5-1 plan	13,000	$59.26	$770K	52,699	Form 4
Mar 11, 2026Form 4	Lippis Daniel J.CVP, TAVRExercise or conversion · $60K · 1,019 sh · 10b5-1	Exercise or conversion· 10b5-1 plan	1,019	$59.26	$60K	34,952.91	Form 4
Mar 11, 2026Form 4	Ullem Scott B.CVP, Chief Financial OfficerExercise or conversion · Employee Stock Option (Rig… · $0 · 13,000 sh · 10b5-1	Exercise or conversion· Employee Stock Option (Rig…· 10b5-1 plan	13,000	$0.00	$0	26,000	Form 4
Mar 11, 2026Form 4	Lippis Daniel J.CVP, TAVRExercise or conversion · Employee Stock Option (Rig… · $0 · 1,019 sh · 10b5-1	Exercise or conversion· Employee Stock Option (Rig…· 10b5-1 plan	1,019	$0.00	$0	3,057	Form 4
Mar 2, 2026Form 4	BOBO DONALD E JRCVP,Strategy/Corp DevelopmentExercise or conversion · $672K · 11,340 sh · 10b5-1	Exercise or conversion· 10b5-1 plan	11,340	$59.26	$672K	32,606.253	Form 4
Mar 2, 2026Form 4	BOBO DONALD E JRCVP,Strategy/Corp DevelopmentExercise or conversion · Employee Stock Option (Rig… · $0 · 11,340 sh · 10b5-1	Exercise or conversion· Employee Stock Option (Rig…· 10b5-1 plan	11,340	$0.00	$0	22,680	Form 4
Feb 22, 2026Form 4	Lippis Daniel J.CVP, TAVRTax withholding · $34K · 432 sh	Tax withholding	432	$79.78	$34K	33,933.91	Form 4
Feb 22, 2026Form 4	Dahl Andrew M.SVP, Corporate ControllerTax withholding · $14K · 176 sh	Tax withholding	176	$79.78	$14K	9,089.481	Form 4
Feb 17, 2026Form 4	Lippis Daniel J.CVP, TAVRTax withholding · $15K · 198 sh	Tax withholding	198	$75.87	$15K	34,365.91	Form 4
Feb 16, 2026Form 4	Lippis Daniel J.CVP, TAVRTax withholding · $20K · 258 sh	Tax withholding	258	$75.87	$20K	34,563.91	Form 4
Feb 16, 2026Form 4	Ullem Scott B.CVP, Chief Financial OfficerTax withholding · $15K · 199 sh	Tax withholding	199	$75.87	$15K	39,699	Form 4
Feb 13, 2026Form 4	Zovighian Bernard JCEO · DirectorGift · $0 · 5,840 sh	Gift	5,840	$0.00	$0	92,492.551	Form 4
Feb 12, 2026Form 4	Zovighian Bernard JCEO · DirectorExercise or conversion · $1.5M · 25,350 sh	Exercise or conversion	25,350	$59.26	$1.5M	106,326	Form 4
Feb 12, 2026Form 4	Zovighian Bernard JCEO · DirectorExercise or conversion · Employee Stock Option (Rig… · $0 · 25,350 sh	Exercise or conversion· Employee Stock Option (Rig…	25,350	$0.00	$0	0	Form 4
Feb 12, 2026Form 4	Lippis Daniel J.CVP, TAVRAward · $0 · 12,820 sh	Award	12,820	$0.00	$0	34,821.91	Form 4
Jan 9, 2026Form 4	Lippis Daniel J.CVP, TAVRExercise or conversion · $60K · 1,019 sh · 10b5-1	Exercise or conversion· 10b5-1 plan	1,019	$59.26	$60K	23,020.91	Form 4
Jan 9, 2026Form 4	Lippis Daniel J.CVP, TAVRExercise or conversion · Employee Stock Option (Rig… · $0 · 1,019 sh · 10b5-1	Exercise or conversion· Employee Stock Option (Rig…· 10b5-1 plan	1,019	$0.00	$0	4,076	Form 4
Jan 6, 2026Form 4	BOBO DONALD E JRCVP,Strategy/Corp DevelopmentExercise or conversion · $672K · 11,340 sh · 10b5-1	Exercise or conversion· 10b5-1 plan	11,340	$59.26	$672K	43,210.253	Form 4
Jan 6, 2026Form 4	BOBO DONALD E JRCVP,Strategy/Corp DevelopmentExercise or conversion · Employee Stock Option (Rig… · $0 · 11,340 sh · 10b5-1	Exercise or conversion· Employee Stock Option (Rig…· 10b5-1 plan	11,340	$0.00	$0	34,020	Form 4

Reports and proxy statements#

Annual reports (10-K, 20-F, 40-F), quarterly reports (10-Q), current reports (8-K, 6-K) and proxy statements, newest first. An 8-K that furnishes a press release is headed by the release’s headline, its items beneath; any other 8-K is described by its items. A form opens the press release where there is one, else the document on EDGAR, or the filing’s index where it furnishes other exhibits.

2026 · 14 filings

Filed	Form	What it is	Period
Aug 28, 20268-K	8-K	Directors or officers; compensation	Aug 25, 2026
Aug 4, 202610-Q	10-Q	Quarterly report, Q2 2026 — revenue $1.74B (+14% y/y), net income $241.9M, EPS $0.42	Jun 30, 2026
Jul 23, 20268-K	8-K	Earnings release — EPS $0.78 vs $0.73 est. (+6.8%); revenue $1.74B (+14% y/y) 1.4%	Jul 23, 2026
May 8, 20268-K	8-K	Directors or officers; compensation; Shareholder vote results	May 7, 2026
May 6, 202610-Q	10-Q	Quarterly report, Q1 2026 — revenue $1.65B (+17% y/y), net income $380.7M, EPS $0.66	Mar 31, 2026
May 4, 20268-K	8-K	Directors or officers; compensation; Regulation FD disclosure	May 2, 2026
Apr 23, 20268-K	8-K	Earnings release — EPS $0.78 vs $0.75 est. (+4.0%); revenue $1.65B (+17% y/y) 5.6%	Apr 23, 2026
Mar 26, 2026DEFA14A	DEFA14A	Additional proxy materials	—
Mar 26, 2026ARS	ARS	Annual report to shareholders	Dec 31, 2025
Mar 26, 2026DEFA14A	DEFA14A	Additional proxy materials	—
Mar 26, 2026DEF 14A	DEF 14A	Proxy statement	May 7, 2026
Feb 25, 202610-K	10-K	Annual report, FY2025 — revenue $6.07B (+12% y/y), net income $1.07B, EPS $1.83	Dec 31, 2025
Feb 10, 20268-K	8-K	Earnings release — EPS $0.58 vs $0.62 est. (−6.5%); revenue $1.57B (+13% y/y) 3.0%	Feb 10, 2026
Jan 12, 20268-K	8-K	Regulation FD disclosure	Jan 9, 2026

2025 · 18 filings

Filed	Form	What it is	Period
Nov 5, 202510-Q	10-Q	Quarterly report, Q3 2025 — revenue $1.55B (+15% y/y), net income $291.1M, EPS $0.50	Sep 30, 2025
Oct 30, 20258-K	8-K	Directors or officers; compensation; Regulation FD disclosure	Oct 30, 2025
Oct 30, 20258-K	8-K	Earnings release — EPS $0.67 vs $0.59 est. (+13.6%); revenue $1.55B (+15% y/y) 1.2%	Oct 30, 2025
Aug 19, 20258-K	8-K	Other events	Aug 19, 2025
Aug 6, 202510-Q	10-Q	Quarterly report, Q2 2025 — revenue $1.53B (+12% y/y), net income $333.2M, EPS $0.56	Jun 30, 2025
Aug 6, 20258-K	8-K	Regulation FD disclosure	Aug 6, 2025
Jul 25, 20258-K	8-K	Directors or officers; compensation	Jul 21, 2025
Jul 24, 20258-K	8-K	Earnings release — EPS $0.67 vs $0.62 est. (+8.1%); revenue $1.53B (+12% y/y) 5.5%	Jul 24, 2025
May 8, 20258-K	8-K	Directors or officers; compensation; Shareholder vote results	May 8, 2025
May 6, 202510-Q	10-Q	Quarterly report, Q1 2025 — revenue $1.41B (+6% y/y), net income $358.0M, EPS $0.61	Mar 31, 2025
Apr 23, 20258-K	8-K	Earnings release — EPS $0.64 vs $0.60 est. (+6.7%); revenue $1.41B (+6% y/y) 6.6%	Apr 23, 2025
Apr 14, 2025DEFA14A	DEFA14A	Additional proxy materials	—
Mar 26, 2025ARS	ARS	Annual report to shareholders	Dec 31, 2024
Mar 26, 2025DEFA14A	DEFA14A	Additional proxy materials	—
Mar 26, 2025DEFA14A	DEFA14A	Additional proxy materials	—
Mar 26, 2025DEF 14A	DEF 14A	Proxy statement	Dec 31, 2024
Feb 28, 202510-K	10-K	Annual report, FY2024 — revenue $5.44B (+9% y/y), net income $4.17B, EPS $6.97	Dec 31, 2024
Feb 11, 20258-K	8-K	Earnings release — EPS $0.59 vs $0.55 est. (+7.3%); revenue $1.39B (+9% y/y) 6.9%	Feb 11, 2025

2024 · 19 filings

Filed	Form	What it is	Period
Nov 6, 202410-Q	10-Q	Quarterly report, Q3 2024 — revenue $1.35B (+9% y/y), net income $3.07B, EPS $5.13	Sep 30, 2024
Oct 24, 20248-K	8-K	Earnings release — EPS $0.67 vs $0.67 est.; revenue $1.35B (+9% y/y) 1.4%	Oct 24, 2024
Sep 3, 20248-K	8-K	Regulation FD disclosure	Sep 3, 2024
Jul 31, 202410-Q	10-Q	Quarterly report, Q2 2024 — revenue $1.37B (+7% y/y), net income $366.3M, EPS $0.61	Jun 30, 2024
Jul 24, 20248-K	8-K	Earnings release — EPS $0.70 vs $0.70 est.; revenue $1.37B (+7% y/y) 31.3%	Jul 24, 2024
Jul 15, 20248-K	8-K	Regulation FD disclosure; Other events	Jul 15, 2024
Jul 10, 20248-K	8-K	Directors or officers; compensation	Jul 10, 2024
Jun 17, 20248-K	8-K	Directors or officers; compensation	Jun 14, 2024
Jun 3, 20248-K	8-K	Regulation FD disclosure; Other events	Jun 3, 2024
May 8, 20248-K	8-K	Shareholder vote results	May 7, 2024
Apr 29, 202410-Q	10-Q	Quarterly report, Q1 2024 — revenue $1.33B (+9% y/y), net income $351.9M, EPS $0.58	Mar 31, 2024
Apr 25, 20248-K	8-K	Earnings release — EPS $0.66 vs $0.64 est. (+3.1%); revenue $1.33B (+9% y/y) 1.8%	Apr 25, 2024
Mar 26, 2024ARS	ARS	Annual report to shareholders	Dec 31, 2023
Mar 26, 2024DEFA14A	DEFA14A	Additional proxy materials	—
Mar 26, 2024DEFA14A	DEFA14A	Additional proxy materials	—
Mar 26, 2024DEF 14A	DEF 14A	Proxy statement	Dec 31, 2023
Mar 26, 20248-K	8-K	Directors or officers; compensation	Mar 26, 2024
Feb 12, 202410-K	10-K	Annual report, FY2023 — revenue $5.01B (+12% y/y), net income $1.40B, EPS $2.30	Dec 31, 2023
Feb 6, 20248-K	8-K	Earnings release — EPS $0.64 vs $0.64 est.; revenue $1.27B (+195% y/y) 1.9%	Feb 6, 2024

2023 · 16 filings — 7 × 8-K, 3 × 10-Q, 2 × DEFA14A and 4 other forms

Filed	Form	What it is	Period
Oct 27, 202310-Q	10-Q	Quarterly report, Q3 2023 — revenue $1.24B (−6% y/y), net income $384.9M, EPS $0.63	Sep 30, 2023
Jul 28, 202310-Q	10-Q	Quarterly report, Q2 2023 — revenue $1.28B (−7% y/y), net income $307.1M, EPS $0.50	Jun 30, 2023
Apr 28, 202310-Q	10-Q	Quarterly report, Q1 2023 — revenue $1.22B (−9% y/y), net income $340.5M, EPS $0.56	Mar 31, 2023
Mar 28, 2023ARS	ARS	Annual report to shareholders	Dec 31, 2022
Mar 28, 2023DEFA14A	DEFA14A	Additional proxy materials	—
Mar 28, 2023DEFA14A	DEFA14A	Additional proxy materials	—
Mar 28, 2023DEF 14A	DEF 14A	Proxy statement	—
Mar 14, 2023PRE 14A	PRE 14A	Preliminary proxy statement	—
Feb 13, 202310-K	10-K	Annual report, FY2022 — revenue $4.46B (−15% y/y), net income $1.52B, EPS $2.44	Dec 31, 2022

7 current reports (8-K) not listed; the year is on EDGAR.

2022 · 15 filings — 8 × 8-K, 3 × 10-Q, 2 × DEFA14A and 2 other forms

Filed	Form	What it is	Period
Oct 28, 202210-Q	10-Q	Quarterly report, Q3 2022 — revenue $1.32B (+1% y/y), net income $343.5M, EPS $0.55	Sep 30, 2022
Jul 29, 202210-Q	10-Q	Quarterly report, Q2 2022 — revenue $1.37B (−0% y/y), net income $406.4M, EPS $0.65	Jun 30, 2022
Apr 28, 202210-Q	10-Q	Quarterly report, Q1 2022 — revenue $1.34B (+10% y/y), net income $373.6M, EPS $0.59	Mar 31, 2022
Mar 22, 2022DEFA14A	DEFA14A	Additional proxy materials	—
Mar 22, 2022DEFA14A	DEFA14A	Additional proxy materials	—
Mar 22, 2022DEF 14A	DEF 14A	Proxy statement	May 3, 2022
Feb 14, 202210-K	10-K	Annual report, FY2021 — revenue $5.23B (+19% y/y), net income $1.50B, EPS $2.38	Dec 31, 2021

8 current reports (8-K) not listed; the year is on EDGAR.

2021 · 13 filings — 6 × 8-K, 3 × 10-Q, 2 × DEFA14A and 2 other forms

Filed	Form	What it is	Period
Oct 29, 202110-Q	10-Q	Quarterly report, Q3 2021 — revenue $1.31B (+15% y/y), net income $340.1M, EPS $0.54	Sep 30, 2021
Jul 30, 202110-Q	10-Q	Quarterly report, Q2 2021 — revenue $1.38B (+49% y/y), net income $489.5M, EPS $0.78	Jun 30, 2021
Apr 28, 202110-Q	10-Q	Quarterly report, Q1 2021 — revenue $1.22B (+8% y/y), net income $338.2M, EPS $0.54	Mar 31, 2021
Mar 23, 2021DEFA14A	DEFA14A	Additional proxy materials	—
Mar 23, 2021DEFA14A	DEFA14A	Additional proxy materials	—
Mar 23, 2021DEF 14A	DEF 14A	Proxy statement	May 4, 2021
Feb 12, 202110-K	10-K	Annual report, FY2020 — revenue $4.39B (+1% y/y), net income $823.4M, EPS $1.30	Dec 31, 2020

6 current reports (8-K) not listed; the year is on EDGAR.

2020 · 16 filings — 7 × 8-K, 3 × 10-Q, 3 × DEFA14A and 3 other forms

Filed	Form	What it is	Period
Oct 26, 202010-Q	10-Q	Quarterly report, Q3 2020 — revenue $1.14B (+4% y/y), net income $325.2M, EPS $0.52	Sep 30, 2020
Jul 27, 202010-Q	10-Q	Quarterly report, Q2 2020 — revenue $925.0M (−15% y/y), net income −$121.9M, EPS −$0.20	Jun 30, 2020
Apr 28, 202010-Q	10-Q	Quarterly report, Q1 2020 — revenue $1.13B (+14% y/y), net income $310.6M, EPS $0.49	Mar 31, 2020
Apr 13, 2020DEFA14A	DEFA14A	Additional proxy materials	—
Mar 25, 2020DEFA14A	DEFA14A	Additional proxy materials	—
Mar 25, 2020DEFA14A	DEFA14A	Additional proxy materials	—
Mar 25, 2020DEF 14A	DEF 14A	Proxy statement	May 7, 2020
Mar 9, 2020PRE 14A	PRE 14A	Preliminary proxy statement	May 7, 2020
Feb 14, 202010-K	10-K	Annual report, FY2019 — revenue $4.35B (+17% y/y), net income $1.05B, EPS $1.64	Dec 31, 2019

7 current reports (8-K) not listed; the year is on EDGAR.

2019 · 13 filings — 6 × 8-K, 3 × 10-Q, 2 × DEFA14A and 2 other forms

Filed	Form	What it is	Period
Oct 25, 201910-Q	10-Q	Quarterly report, Q3 2019 — revenue $1.09B (+21% y/y), net income $274.7M, EPS $0.43	Sep 30, 2019
Jul 26, 201910-Q	10-Q	Quarterly report, Q2 2019 — revenue $1.09B (+15% y/y), net income $242.3M, EPS $0.38	Jun 30, 2019
Apr 26, 201910-Q	10-Q	Quarterly report, Q1 2019 — revenue $993.0M (+11% y/y), net income $249.7M, EPS $0.39	Mar 31, 2019
Mar 27, 2019DEFA14A	DEFA14A	Additional proxy materials	—
Mar 27, 2019DEFA14A	DEFA14A	Additional proxy materials	—
Mar 27, 2019DEF 14A	DEF 14A	Proxy statement	May 8, 2019
Feb 15, 201910-K	10-K	Annual report, FY2018 — revenue $3.72B (+8% y/y), net income $722.2M, EPS $1.13	Dec 31, 2018

6 current reports (8-K) not listed; the year is on EDGAR.

2018 · 18 filings — 10 × 8-K, 3 × 10-Q, 2 × DEFA14A and 3 other forms

Filed	Form	What it is	Period
Oct 26, 201810-Q	10-Q	Quarterly report, Q3 2018 — revenue $906.6M (+10% y/y), net income $225.9M, EPS $1.06	Sep 30, 2018
Jul 27, 201810-Q	10-Q	Quarterly report, Q2 2018 — revenue $943.7M (+12% y/y), net income $282.7M, EPS $1.32	Jun 30, 2018
Apr 27, 201810-Q	10-Q	Quarterly report, Q1 2018 — revenue $894.8M (+1% y/y), net income $206.6M, EPS $0.96	Mar 31, 2018
Apr 12, 2018DEFA14A	DEFA14A	Additional proxy materials	—
Mar 29, 2018DEFA14A	DEFA14A	Additional proxy materials	—
Mar 29, 2018DEF 14A	DEF 14A	Proxy statement	May 17, 2018
Feb 16, 201810-K	10-K	Annual report, FY2017 — revenue $3.44B (+16% y/y), net income $583.6M, EPS $2.70	Dec 31, 2017

11 current reports (8-K) not listed; the year is on EDGAR.

2017 · 13 filings — 7 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms

Filed	Form	What it is	Period
Oct 27, 201710-Q	10-Q	Quarterly report, Q3 2017 — revenue $821.5M (+11% y/y), net income $170.1M, EPS $0.79	Sep 30, 2017
Jul 28, 201710-Q	10-Q	Quarterly report, Q2 2017 — revenue $841.8M (+11% y/y), net income $186.1M, EPS $0.86	Jun 30, 2017
Apr 28, 201710-Q	10-Q	Quarterly report, Q1 2017 — revenue $883.5M (+27% y/y), net income $230.2M, EPS $1.06	Mar 31, 2017
Mar 31, 2017DEFA14A	DEFA14A	Additional proxy materials	—
Mar 30, 2017DEF 14A	DEF 14A	Proxy statement	May 11, 2017
Feb 17, 201710-K	10-K	Annual report, FY2016 — revenue $2.96B (+19% y/y), net income $569.5M, EPS $2.61	Dec 31, 2016

7 current reports (8-K) not listed; the year is on EDGAR.

2016 · 15 filings — 9 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms

Counted, not listed; the year is on EDGAR.

2015 · 16 filings — 10 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms

Counted, not listed; the year is on EDGAR.

2014 · 18 filings — 11 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms

Counted, not listed; the year is on EDGAR.

2013 · 19 filings — 13 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms

Counted, not listed; the year is on EDGAR.

2012 · 12 filings — 7 × 8-K, 3 × 10-Q, 1 × 10-K and 1 other form

Counted, not listed; the year is on EDGAR.

2011 · 12 filings — 7 × 8-K, 3 × 10-Q, 1 × 10-K and 1 other form

Counted, not listed; the year is on EDGAR.

2010 · 12 filings — 7 × 8-K, 3 × 10-Q, 1 × 10-K and 1 other form

Counted, not listed; the year is on EDGAR.

2009 · 11 filings — 6 × 8-K, 3 × 10-Q, 1 × 10-K and 1 other form

Counted, not listed; the year is on EDGAR.

2008 · 14 filings — 9 × 8-K, 3 × 10-Q, 1 × 10-K and 1 other form

Counted, not listed; the year is on EDGAR.

2007 · 14 filings — 9 × 8-K, 3 × 10-Q, 1 × 10-K and 1 other form

Counted, not listed; the year is on EDGAR.

2006 · 15 filings — 10 × 8-K, 3 × 10-Q, 1 × 10-K and 1 other form

Counted, not listed; the year is on EDGAR.

2005 · 13 filings — 8 × 8-K, 3 × 10-Q, 1 × 10-K and 1 other form

Counted, not listed; the year is on EDGAR.

2004 · 15 filings — 9 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms

Counted, not listed; the year is on EDGAR.

2003 · 19 filings — 9 × 8-K, 3 × 10-Q, 2 × 10-Q/A and 5 other forms

Counted, not listed; the year is on EDGAR.

2002 · 6 filings — 3 × 10-Q, 1 × 10-K405, 1 × ARS and 1 other form

Counted, not listed; the year is on EDGAR.

2001 · 7 filings — 3 × 10-Q, 1 × 10-K, 1 × 8-K and 2 other forms

Counted, not listed; the year is on EDGAR.

2000 · 4 filings — 3 × 10-Q, 1 × 8-K

Counted, not listed; the year is on EDGAR.

Insider, ownership and other filings#

Insider ownership (Forms 3, 4, 5 and 144), beneficial ownership (Schedules 13D and 13G), registration and prospectus (S-1, S-3, S-8, 424B and related) and the rest, counted by year, with the newest 25 of each of the latest 3 years shown. A Form 4 is one insider’s transaction report; a 13G is a passive holder above five percent.

2026 · 94 filings — 64 × 4, 23 × 144, 2 × 11-K and 5 other forms

Filed	Form	What it is	Period
Oct 8, 20264	4	Insider transaction (Form 4)	Oct 8, 2026
Sep 14, 20264	4	Insider transaction (Form 4)	Sep 11, 2026
Sep 14, 20264	4	Insider transaction (Form 4)	Sep 13, 2026
Sep 11, 20264	4	Insider transaction (Form 4)	Sep 11, 2026
Sep 11, 20264	4	Insider transaction (Form 4)	Sep 11, 2026
Aug 31, 20264	4	Insider transaction (Form 4)	Aug 31, 2026
Aug 31, 2026144	144	Notice of proposed sale (Form 144)	—
Aug 28, 20264	4	Insider transaction (Form 4)	Aug 28, 2026
Aug 28, 2026144	144	Notice of proposed sale (Form 144)	—
Aug 26, 20264	4	Insider transaction (Form 4)	Aug 26, 2026
Aug 26, 20264	4	Insider transaction (Form 4)	Aug 26, 2026
Aug 26, 2026144	144	Notice of proposed sale (Form 144)	—
Aug 26, 2026144	144	Notice of proposed sale (Form 144)	—
Aug 11, 20264	4	Insider transaction (Form 4)	Aug 11, 2026
Aug 11, 2026144	144	Notice of proposed sale (Form 144)	—
Aug 4, 2026S-8	S-8	Employee stock plan registration	—
Jul 30, 20264	4	Insider transaction (Form 4)	Jul 30, 2026
Jul 30, 2026144	144	Notice of proposed sale (Form 144)	—
Jul 30, 2026144	144	Notice of proposed sale (Form 144)	—
Jul 28, 20264	4	Insider transaction (Form 4)	Jul 28, 2026
Jul 28, 2026144	144	Notice of proposed sale (Form 144)	—
Jul 27, 20264	4	Insider transaction (Form 4)	Jul 27, 2026
Jul 27, 2026144	144	Notice of proposed sale (Form 144)	—
Jul 13, 20264	4	Insider transaction (Form 4)	Jul 11, 2026
Jul 10, 20264	4	Insider transaction (Form 4)	Jul 9, 2026

The newest 25 of 94 shown; the full year is on EDGAR.

2025 · 113 filings — 71 × 4, 32 × 144, 3 × SCHEDULE 13G/A and 5 other forms

Filed	Form	What it is	Period
Dec 12, 20254	4	Insider transaction (Form 4)	Dec 12, 2025
Dec 12, 20254	4	Insider transaction (Form 4)	Dec 12, 2025
Dec 12, 20254	4	Insider transaction (Form 4)	Dec 12, 2025
Dec 12, 2025144	144	Notice of proposed sale (Form 144)	—
Dec 12, 2025144	144	Notice of proposed sale (Form 144)	—
Dec 12, 2025144	144	Notice of proposed sale (Form 144)	—
Dec 11, 20254	4	Insider transaction (Form 4)	Dec 11, 2025
Dec 11, 2025144	144	Notice of proposed sale (Form 144)	—
Dec 10, 20254	4	Insider transaction (Form 4)	Dec 10, 2025
Dec 10, 20254	4	Insider transaction (Form 4)	Dec 8, 2025
Dec 10, 2025144	144	Notice of proposed sale (Form 144)	—
Dec 10, 2025144	144	Notice of proposed sale (Form 144)	—
Dec 9, 20254	4	Insider transaction (Form 4)	Dec 9, 2025
Dec 8, 20254	4	Insider transaction (Form 4)	Dec 8, 2025
Dec 8, 2025144	144	Notice of proposed sale (Form 144)	—
Dec 8, 2025144	144	Notice of proposed sale (Form 144)	—
Nov 13, 20254	4	Insider transaction (Form 4)	Nov 13, 2025
Nov 12, 2025144	144	Notice of proposed sale (Form 144)	—
Nov 10, 20254	4	Insider transaction (Form 4)	Nov 10, 2025
Nov 10, 20254	4	Insider transaction (Form 4)	Nov 10, 2025
Nov 10, 2025144	144	Notice of proposed sale (Form 144)	—
Nov 10, 2025144	144	Notice of proposed sale (Form 144)	—
Oct 17, 2025SCHEDULE 13G/A	SCHEDULE 13G/A	Other filings	—
Oct 16, 2025144	144	Notice of proposed sale (Form 144)	—
Sep 15, 20254	4	Insider transaction (Form 4)	Sep 13, 2025

The newest 25 of 113 shown; the full year is on EDGAR.

2024 · 129 filings — 88 × 4, 27 × 144, 5 × 3 and 6 other forms

Filed	Form	What it is	Period
Dec 16, 20244	4	Insider transaction (Form 4)	Dec 16, 2024
Dec 16, 2024144	144	Notice of proposed sale (Form 144)	—
Dec 9, 20244	4	Insider transaction (Form 4)	Dec 9, 2024
Dec 9, 20244	4	Insider transaction (Form 4)	Dec 9, 2024
Dec 9, 2024144	144	Notice of proposed sale (Form 144)	—
Dec 6, 20244	4	Insider transaction (Form 4)	Dec 6, 2024
Dec 6, 20244	4	Insider transaction (Form 4)	Dec 6, 2024
Dec 6, 2024144	144	Notice of proposed sale (Form 144)	—
Dec 6, 2024144	144	Notice of proposed sale (Form 144)	—
Nov 13, 20244	4	Insider transaction (Form 4)	Nov 13, 2024
Nov 13, 2024144	144	Notice of proposed sale (Form 144)	—
Nov 8, 2024SC 13G	SC 13G	Passive holder above 5% (Schedule 13G)	—
Nov 5, 20244	4	Insider transaction (Form 4)	Nov 5, 2024
Nov 5, 2024144	144	Notice of proposed sale (Form 144)	—
Oct 15, 20244	4	Insider transaction (Form 4)	Oct 15, 2024
Oct 4, 2024SC 13G/A	SC 13G/A	Passive holder above 5% (Schedule 13G), amended	—
Sep 16, 20244	4	Insider transaction (Form 4)	Sep 14, 2024
Sep 16, 20244	4	Insider transaction (Form 4)	Sep 13, 2024
Sep 11, 20244	4	Insider transaction (Form 4)	Sep 11, 2024
Sep 3, 20244	4	Insider transaction (Form 4)	Sep 3, 2024
Aug 20, 20244	4	Insider transaction (Form 4)	Aug 20, 2024
Aug 20, 2024144	144	Notice of proposed sale (Form 144)	—
Aug 19, 20243	3	Initial insider holdings (Form 3)	Aug 19, 2024
Aug 14, 20244	4	Insider transaction (Form 4)	Aug 14, 2024
Aug 14, 2024144	144	Notice of proposed sale (Form 144)	—

The newest 25 of 129 shown; the full year is on EDGAR.

2023 · 126 filings — 97 × 4, 21 × 144, 2 × 11-K and 4 other forms

Counted, not listed; the year is on EDGAR.

2022 · 107 filings — 94 × 4, 2 × 11-K, 2 × 3 and 7 other forms

Counted, not listed; the year is on EDGAR.

2021 · 118 filings — 110 × 4, 2 × 11-K, 2 × S-8 and 3 other forms

Counted, not listed; the year is on EDGAR.

2020 · 111 filings — 103 × 4, 2 × 11-K, 2 × 3 and 3 other forms

Counted, not listed; the year is on EDGAR.

2019 · 115 filings — 107 × 4, 2 × 11-K, 1 × 3 and 5 other forms

Counted, not listed; the year is on EDGAR.

2018 · 112 filings — 102 × 4, 2 × 11-K, 1 × 3 and 7 other forms

Counted, not listed; the year is on EDGAR.

2017 · 83 filings — 72 × 4, 3 × SC 13G/A, 2 × 11-K and 6 other forms

Counted, not listed; the year is on EDGAR.

2016 · 94 filings — 81 × 4, 3 × 3, 2 × 11-K and 7 other forms

Counted, not listed; the year is on EDGAR.

2015 · 90 filings — 72 × 4, 7 × SC 13G/A, 3 × 3 and 5 other forms

Counted, not listed; the year is on EDGAR.

2014 · 94 filings — 79 × 4, 6 × SC 13G/A, 3 × 3 and 4 other forms

Counted, not listed; the year is on EDGAR.

2013 · 89 filings — 73 × 4, 8 × SC 13G/A, 2 × 11-K and 6 other forms

Counted, not listed; the year is on EDGAR.

2012 · 137 filings — 121 × 4, 4 × 4/A, 4 × SC 13G and 4 other forms

Counted, not listed; the year is on EDGAR.

2011 · 81 filings — 73 × 4, 3 × SC 13G/A, 2 × 11-K and 3 other forms

Counted, not listed; the year is on EDGAR.

2010 · 91 filings — 78 × 4, 4 × SC 13G/A, 2 × 11-K and 5 other forms

Counted, not listed; the year is on EDGAR.

2009 · 68 filings — 59 × 4, 5 × SC 13G/A, 2 × 11-K and 2 other forms

Counted, not listed; the year is on EDGAR.

2008 · 72 filings — 53 × 4, 4 × 3, 3 × SC 13G and 6 other forms

Counted, not listed; the year is on EDGAR.

2007 · 74 filings — 63 × 4, 3 × CORRESP, 3 × SC 13G/A and 3 other forms

Counted, not listed; the year is on EDGAR.

2006 · 61 filings — 47 × 4, 3 × SC 13G/A, 3 × UPLOAD and 5 other forms

Counted, not listed; the year is on EDGAR.

2005 · 53 filings — 44 × 4, 3 × SC 13G/A, 2 × 11-K and 4 other forms

Counted, not listed; the year is on EDGAR.

2004 · 52 filings — 38 × 4, 4 × SC 13G/A, 3 × 3 and 4 other forms

Counted, not listed; the year is on EDGAR.

2003 · 32 filings — 12 × 4, 5 × 424B3, 5 × SC 13G/A and 6 other forms

Counted, not listed; the year is on EDGAR.

2002 · 7 filings — 2 × 11-K, 2 × SC 13G, 2 × SC 13G/A and 1 other form

Counted, not listed; the year is on EDGAR.

2001 · 9 filings — 3 × SC 13G, 2 × 11-K, 2 × NT 11-K and 2 other forms

Counted, not listed; the year is on EDGAR.

2000 · 12 filings — 6 × S-8, 5 × 10-12B/A, 1 × 8-A12B

Counted, not listed; the year is on EDGAR.

1999 · 1 filing — 1 × 10-12B

Counted, not listed; the year is on EDGAR.

About this data#

Edwards Lifesciences Corporation (EW) has 2,602 filings on EDGAR going back to 1999: 27 annual reports, 82 quarterly reports and 205 current reports, plus proxy statements, insider forms and ownership schedules. Its latest annual report, a 10-K, was filed on Feb 25, 2026 for the fiscal year ended Dec 31, 2025. The most recent 8-K, on Aug 28, 2026, covered directors or officers; compensation. Over the last 13 months insiders sold $21.3M in 32 sales and bought nothing on the open market; 122 other transactions (awards, exercises, tax withholding, gifts and plan purchases). Not investment advice.

Every row is a filing EDGAR lists for the registrants that have been Edwards Lifesciences Corporation, read from the SEC’s submissions index each morning; a filing accepted after that read appears the next day. Where a company changed its filing entity (a holding-company reorganisation, Google into Alphabet) the predecessor’s filings are shown for the years it filed as the company, derived from the filings themselves. Dates are the filing date; the period is the report’s own. The latest 3 years of reports are listed in full, the next years to 10 without their 8-Ks, and older years are counted; the other forms are counted too, with the newest 25 of each of the latest 3 years shown. Insider transactions are the Form 4 and Form 5 documents themselves, filed since January 2026, every number as the insider filed it: a day’s lots are summed, a blank price adds its shares and no dollars, and a purchase through an employee stock plan is a plan purchase, not insider buying. An 8-K’s headline is the first line of the press release it furnishes (Exhibit 99), read from the filing and shown word for word; where two independent readings of the exhibit do not agree, the 8-K is described by its items instead. The documents stay on sec.gov, public domain, and every link opens the SEC’s copy. ChartRow does not summarise or interpret filings.

FAQ#

Where can I read EW's latest 10-K?: EW's latest annual report, a 10-K, was filed on Feb 25, 2026 for the fiscal year ended Dec 31, 2025. It is linked above and opens on EDGAR, the SEC's own site, where every exhibit is also listed.
When did EW last file an 8-K?: On Aug 28, 2026 it covered directors or officers; compensation. An 8-K reports a material event between quarterly reports; the one that furnishes the quarter's results is filed under Item 2.02, last on Jul 23, 2026.
Are EW insiders buying or selling?: Over the last 13 months insiders sold $21.3M in 32 sales and bought nothing on the open market; 122 other transactions (awards, exercises, tax withholding, gifts and plan purchases). The most recent sale: Lippis Daniel J. (CVP, TAVR) sold 619 shares on Oct 8, 2026 for $53K, under a 10b5-1 plan. Every figure is as the insider filed it on Form 4; a sale under a 10b5-1 plan was scheduled in advance.
How many SEC filings has EW made?: 2,602 filings are on EDGAR under the registrant records that have been Edwards Lifesciences Corporation, going back to 1999; 1,965 of them are insider ownership forms (Forms 3, 4, 5 and 144).

EW SEC filings (2026)

What happened, last 12 months#

October 2026

September 2026

August 2026

July 2026

June 2026

May 2026

April 2026

March 2026

February 2026

January 2026

November 2025

October 2025

Insider transactions#

Reports and proxy statements#

Insider, ownership and other filings#

About this data#

FAQ#